Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
US assets seized in Russia
Reveals cancer diagnosis
Calls Trump claim dangerous
Alaska's rivers turn orange
'Quid pro quo' probe
Police officer disciplined
Will miss her ninth Olympics
Harvard grads stage walkout
Mosby spared prison time
Dow drops 600+points
Jolie to produce NDAs
Rise to AI prominence
Expects a 2024 cash burn
Opposes tariffs on CN EVs
FCC fines political consultant
DOJ sues Live Nation
Mortgage rates fall below 7%
Speaks on Diddy abuse video
Fuel tank flaw found in planes
Approves SC voting map
To step down as chairman
Senate downs border bill
Mahomes, Reid back Butker
Hurricane season outlook
University leaders testify
La. criminalizes abortion pills
Cavaliers fire Bickerstaff
US weekly jobless claims fall
AI used to draft deepfake law
$275M military aid for UKR
Limits state-affiliated media
OH train derailment settlement
US new home sales fall
Targets June 1 for launch
Oil prices slip for fourth day
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, FDA and RSV vaccine
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
FDA delays decision on Moderna's RSV shot until the end of May
The FDA needs a few more weeks to decide the fate of Moderna's RSV vaccine, the company announced. A decision is now slated for the end of May, as opposed to May 12.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Key Takeaways Moderna said the Food and Drug Administration (FDA) has delayed its approval decision for the respiratory syncytial virus (RSV) vaccine.The biotech reported it was advised by regulators that their review wouldn't be completed until the end of the month,
Yahoo Finance
13d
FDA delays decision on Moderna RSV vaccine
Moderna on Friday said the Food and
Drug
Administration has postponed an approval
decision
on its experimental
vaccine
for
respiratory syncytial virus
due to “administrative constraints ...
13d
on MSN
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
“The product remains an important contributor to Moderna’s return to growth in 2025 and 2026 breakeven story,” William Blair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback